Literature DB >> 20054006

MRI criteria for MS in patients with clinically isolated syndromes.

X Montalban1, M Tintoré, J Swanton, F Barkhof, F Fazekas, M Filippi, J Frederiksen, L Kappos, J Palace, C Polman, M Rovaris, N de Stefano, A Thompson, T Yousry, A Rovira, D H Miller.   

Abstract

In recent years, criteria for the diagnosis of multiple sclerosis (MS) have changed, mainly due to the incorporation of new MRI criteria. While the new criteria are a logical step forward, they are complex and-not surprisingly-a good working knowledge of them is not always evident among neurologists and neuroradiologists. In some circumstances, several MRI examinations are needed to achieve an accurate and prompt diagnosis. This provides an incentive for continued efforts to refine the incorporation of MRI-derived information into the diagnostic workup of patients presenting with a clinically isolated syndrome. Within the European multicenter collaborative research network that studies MRI in MS (MAGNIMS), a workshop was held in London in November 2007 to review information that may simplify the existing MS diagnostic criteria, while maintaining a high specificity that is essential to minimize false positive diagnoses. New data that are now published were reviewed and discussed and together with a new proposal are integrated in this position paper.

Entities:  

Mesh:

Year:  2010        PMID: 20054006     DOI: 10.1212/WNL.0b013e3181cec45c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  63 in total

1.  Spinal cord ischemia: aetiology, clinical syndromes and imaging features.

Authors:  Stefan Weidauer; Michael Nichtweiß; Elke Hattingen; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2014-11-16       Impact factor: 2.804

2.  Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.

Authors:  Adriana Carrá; Miguel Ángel Macías-Islas; Alberto Alan Gabbai; Jorge Correale; Carlos Bolaña; Eduardo Duriez Sotelo; Juan García Bonitto; Fernando Vergara-Edwards; Darwin Vizcarra-Escobar
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

3.  Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?

Authors:  Fatih Kantarci; Sait Albayram; Nuri Onat Demirci; Asim Esenkaya; Derya Uluduz; Omer Uysal; Sabahattin Saip; Aksel Siva
Journal:  Eur Radiol       Date:  2011-11-29       Impact factor: 5.315

4.  From injection therapies to natalizumab: views on the treatment of multiple sclerosis.

Authors:  Roberto Bomprezzi; Darin T Okuda; Yazan J Alderazi; Olaf Stüve; Elliot M Frohman
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 5.  Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis.

Authors:  M A Rocca; N Anzalone; A Falini; M Filippi
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

6.  Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

Authors:  J-M Tillema; S D Weigand; M Dayan; Y Shu; O H Kantarci; C F Lucchinetti; J D Port
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-26       Impact factor: 3.825

7.  [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria].

Authors:  L Klotz; R Gold; B Hemmer; T Korn; F Zipp; R Hohlfeld; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

Review 8.  Neuroimaging in multiple sclerosis: neurotherapeutic implications.

Authors:  Nancy L Sicotte
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

9.  Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?

Authors:  Bruce A C Cree
Journal:  Nat Rev Neurol       Date:  2014-12-16       Impact factor: 42.937

Review 10.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.